LHA510
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LHA510, covering 2015-09-04 to 2017-11-14. Get the full timeline:
Most recent: Clinical Trial Update: LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration [Phase 2]